Evidence map›Paper›PMID 37373202›Full record

ReviewInternational journal of molecular sciences2023

The Brain Pre-Metastatic Niche: Biological and Technical Advancements.

Maximilian Geissler, Weiyi Jia, Emine Nisanur Kiraz, Ida Kulacz, Xiao Liu, Adrian Rombach, Vincent Prinz, Daniel Jussen, Konstantinos D Kokkaliaris, Hind Medyouf and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. The origin of brain malignancies at the blood-brain barrier.Cellular and molecular life sciences : CMLS · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Maximilian GeisslerDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.ORCID 0000-0003-4256-2151
Weiyi JiaDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.
Emine Nisanur KirazDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.
Ida KulaczDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.
Xiao LiuDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.
Adrian RombachDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.ORCID 0000-0002-4310-4374
Vincent PrinzDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.
Daniel JussenDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.ORCID 0000-0002-4303-6957
Konstantinos D KokkaliarisDr. Senckenberg Institute of Pathology, University Hospital Frankfurt, 60528 Frankfurt am Main, Germany.ORCID 0000-0002-9952-3463
Hind MedyoufGerman Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, 60528 Frankfurt am Main, Germany.
Lisa SevenichGerman Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, 60528 Frankfurt am Main, Germany.ORCID 0000-0002-6543-6273
Marcus CzabankaDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.
Thomas BrogginiDepartment of Neurosurgery, University Hospital, Goethe-University, 60528 Frankfurt am Main, Germany.ORCID 0000-0002-3733-486X
Goethe University Frankfurt · DEGerman Cancer Research Center · DE

Funding

Frankfurt Cancer Institute III L 5-519/03/03.001-(0015)
6 · The paper itself

Abstract

Metastasis, particularly brain metastasis, continues to puzzle researchers to this day, and exploring its molecular basis promises to break ground in developing new strategies for combatting this deadly cancer. In recent years, the research focus has shifted toward the earliest steps in the formation of metastasis. In this regard, significant progress has been achieved in understanding how the primary tumor affects distant organ sites before the arrival of tumor cells. The term pre-metastatic niche was introduced for this concept and encompasses all influences on sites of future metastases, ranging from immunological modulation and ECM remodeling to the softening of the blood-brain barrier. The mechanisms governing the spread of metastasis to the brain remain elusive. However, we begin to understand these processes by looking at the earliest steps in the formation of metastasis. This review aims to present recent findings on the brain pre-metastatic niche and to discuss existing and emerging methods to further explore the field. We begin by giving an overview of the pre-metastatic and metastatic niches in general before focusing on their manifestations in the brain. To conclude, we reflect on the methods usually employed in this field of research and discuss novel approaches in imaging and sequencing.

Indexed as

Brain NeoplasmsTumor MicroenvironmentBlood-Brain BarrierBrainHumansNeoplasm Metastasisadvanced imagingbrain metastasisbrain pre-metastatic nichemetastatic nichepre-metastatic nichesingle-cell sequencingtranscriptomicsvascular niche

Identifiers

PMID37373202
PMCPMC10298140
OpenAlexW4380631058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.